# Swasti Vinayaka (NSE: SVARTCORP) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/SVARTCORP · Pivot · prices to 19 Oct 2026

With a market capitalisation of ₹34 Cr, it ranks 3311th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Financials sector; its industry is Real Estate Services.

Its return on equity was 8.7% in FY25. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹12 Cr (+236.4% year on year) and net profit ₹3 Cr (+189.5%), on a standalone basis. Promoters held 51.00% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹34 Cr |
| ROE | 8.7% (FY25) |
| ROCE | 9.9% (FY25) |
| Debt to equity | 0.52 |

## Quarterly results (₹ crore, standalone)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹12 Cr | +236.4% | ₹3 Cr | +189.5% | ₹0.31 |
| Q3 FY26 | ₹6 Cr | +91.8% | ₹1 Cr | +72.9% | ₹0.09 |
| Q2 FY26 | ₹4 Cr | −47.0% | ₹1 Cr | 0.0% | ₹0.09 |
| Q1 FY26 | ₹10 Cr | +91.9% | ₹1 Cr | +1,218.2% | ₹0.16 |
| Q4 FY25 | ₹3 Cr | +5.1% | ₹1 Cr | +4,650.0% | ₹0.11 |
| Q3 FY25 | ₹3 Cr | +8.9% | ₹0 Cr | −31.4% | ₹0.05 |
| Q2 FY25 | ₹7 Cr | +120.4% | ₹1 Cr | −4.9% | ₹0.09 |
| Q1 FY25 | ₹5 Cr | +79.6% | ₹0 Cr | −78.4% | ₹0.01 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹19 Cr | ₹2 Cr |
| FY24 | ₹12 Cr | ₹2 Cr |
| FY23 | ₹13 Cr | ₹3 Cr |
| FY22 | ₹10 Cr | ₹2 Cr |
| FY21 | ₹8 Cr | ₹2 Cr |
| FY20 | ₹9 Cr | ₹1 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 51.00%
- Non-institutions: 49.00%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Sylph Ind](https://app.pivotnow.in/stock/SYLPH) | — | ₹35 Cr | — | — |
| [Supra Trends](https://app.pivotnow.in/stock/SUPRATRE) | — | ₹35 Cr | — | — |
| [Glance Fin](https://app.pivotnow.in/stock/GLANCE) | — | ₹34 Cr | — | — |
| [Sumedha Fiscal](https://app.pivotnow.in/stock/SUMEDHA) | ₹42.65 | ₹34 Cr | 14.1 | — |
| [Biogen Pharmach](https://app.pivotnow.in/stock/BIOGEN) | — | ₹34 Cr | — | — |
| [Yamini Invt](https://app.pivotnow.in/stock/YAMNINV) | — | ₹33 Cr | — | — |

## Questions and answers

### What is the market cap of Swasti Vinayaka?

Swasti Vinayaka's market capitalisation is ₹34 Cr (₹34 Cr) at the 19 Oct 2026 close, ranking 3311th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Swasti Vinayaka?

Return on equity was 8.7% in FY25 and return on capital employed was 9.9% in FY25 (standalone figures).

### What were Swasti Vinayaka's latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Swasti Vinayaka reported revenue of ₹12 Cr, +236.4% year on year, and net profit of ₹3 Cr, +189.5% year on year.

### What is the shareholding pattern of Swasti Vinayaka?

As of 30 Jun 2026: promoters 51.00%, non-institutions 49.00%.

### Who are Swasti Vinayaka's competitors?

The listed Financials companies closest to Swasti Vinayaka by market cap are Sylph Ind, Supra Trends, Glance Fin, Sumedha Fiscal, Biogen Pharmach and Yamini Invt.

### Is Swasti Vinayaka a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Swasti Vinayaka's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on SVARTCORP against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.